AG-2034

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAG-2034
Drug Alias NameAGL-2034AG-2034
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionStem cell growth factor receptor inhibitorsTyrosine-protein kinase receptor FLT3 inhibitors
TargetsStem cell growth factor receptorTyrosine-protein kinase receptor FLT3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesYissum
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesYissum
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A